|
DVL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.491610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.455400E-01 |
| Normal-vs-Stage2 |
7.044600E-01 |
| Normal-vs-Stage3 |
3.141700E-02 |
| Normal-vs-Stage4 |
2.469000E-01 |
| Stage1-vs-Stage2 |
5.152400E-01 |
| Stage1-vs-Stage3 |
1.172830E-01 |
| Stage1-vs-Stage4 |
8.624800E-01 |
| Stage2-vs-Stage3 |
9.959900E-02 |
| Stage2-vs-Stage4 |
4.741200E-01 |
| Stage3-vs-Stage4 |
3.321800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.468400E-01 |
| Normal-vs-AfricanAmerican |
6.934800E-01 |
| Normal-vs-Asian |
6.886800E-01 |
| Caucasian-vs-AfricanAmerican |
7.014800E-01 |
| Caucasian-vs-Asian |
5.235600E-01 |
| AfricanAmerican-vs-Asian |
9.340200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.949600E-01 |
| Normal-vs-Female |
9.309800E-02 |
| Male-vs-Female |
2.185600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.088600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.828010E-01 |
| Normal-vs-Age(61-80Yrs) |
8.022000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.087000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.213400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.537800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.224200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.312200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.399600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.163200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.309700E-02 |
| Classical-VS-Follicular |
5.695900E-03 |
| Classical-VS-Other |
7.161400E-01 |
| Classical-VS-Normal |
6.410000E-01 |
| Tall-VS-Follicular |
6.850600E-01 |
| Tall-VS-Other |
3.860000E-01 |
| Tall-VS-Normal |
2.106100E-02 |
| Follicular-VS-Other |
5.947000E-01 |
| Follicular-VS-Normal |
2.445700E-02 |
| Other-VS-Normal |
5.958000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.283380E-01 |
| Normal-vs-N1 |
5.812800E-01 |
| N0-vs-N1 |
4.159000E-01 |
|
|
